SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor Technologies Inc is a top trending stock following a significant announcement by a prominent political figure regarding measures to inject liquidity into mortgage markets, aiming to reduce borrowing costs for homebuyers. This news has sparked widespread community optimism, with many anticipating a major resurgence in the real estate sector, potential for increased transaction volume, and speculation about a substantial short squeeze.

SMX (Security Matters) Plc is a holding company, which engages in the provision of authentication solutions. It offers brand protection, authentication, and track and trace technology. The company was founded by Haggai Alon on July 1, 2022 and is headquartered in Dublin, Ireland.

SMX (Security Matters) Plc

SMX (Security Matters) PLC

SMX is trending amid vigorous community discussion following its announcement of converting convertible debt into equity. While some investors interpret this as a positive move to strengthen the company and anticipate a significant short squeeze given its history of extreme volatility and high cost to borrow, others express concern over potential dilution and label it a 'pump and dump' operation, fueling intense debate.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is trending due to recent financial guidance outlining a significant revenue step-down for DefenCath in future years, driven by anticipated changes in reimbursement. This has sparked intense community debate, with many investors expressing frustration and questioning management's strategy, while others view the sharp decline as an overreaction, highlighting the company's pipeline and potential legislative support for kidney care.

Oscar Health, Inc. is a health insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Oscar Health Inc - Ordinary Shares - Class A

Oscar Health is trending due to significant legislative developments surrounding the Affordable Care Act (ACA) subsidies. The House has backed an extension, and while the fate of a clean three-year bill in the Senate is uncertain, the community is actively discussing a likely bipartisan compromise for a shorter extension. This ongoing political debate, coupled with high short interest and recent analyst upgrades, has many anticipating potential volatility and a substantial price movement as clarity emerges.

Rocket Cos., Inc. engages in the provision of a suite of services related to homeownership and other personal financial transactions. It operates through the following segments: Direct to Consumer and Partner Network. The Direct to Consumer segment consists of performance marketing and direct engagement through the Rocket Mortgage App. The Partner Network Segment focuses on partnerships with premier consumer-focused organizations, brokers and mortgage professionals who leverage the platform and scale to provide mortgage solutions to clients. The company was founded by Daniel Gilbert in 1985 and is headquartered in Detroit, MI.

Rocket Companies Inc - Ordinary Shares Class A

Rocket Companies (RKT) is trending with strong community enthusiasm following news of a proposed $200 billion mortgage bond buying plan aimed at lowering rates and boosting housing affordability. Investors are actively discussing the potential for a significant refinancing boom, believing RKT's tech-driven platform is exceptionally positioned to capitalize on a favorable shift in the mortgage market. Sentiment points to continued upside and potential new highs as these catalysts unfold.

Aclarion, Inc. is a healthcare technology company, which engages in the provision of Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. It utilizes Artificial Intelligence to assist in quality control processes that flag spectroscopy data indicative of a poor MRS study. It offers NOCISCAN Suite, a revolutionary software suite that works with existing high field Magnetic Resonance systems and Magnetic Resonance Spectroscopy pulse sequence packages using an optimized protocol to conduct MRS exams of lumbar discs. The company was founded by James C. Peacock, David S. Bradford, and Jeffrey Lotz in 2008 and is headquartered in Broomfield, CO.

Aclarion Inc

ACON is trending following positive corporate updates touting triple-digit growth in its AI back pain platform, Nociscan, along with a strong cash position and extended financial runway. The community is sharply divided; bulls point to the low float and potential for a significant short squeeze, while bears express deep skepticism given the company's history of reverse splits and alleged manipulation.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network (ZBCN) is trending as the community eagerly discusses its recently achieved ISO 20022 compliance and the highly anticipated launch of its "Super App." Enthusiastic holders emphasize ZBCN's real-world utility in transforming payments and payroll, often comparing its potential to early-stage XRP and XLM while actively accumulating tokens for long-term growth.

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Revolution Medicines Inc

Revolution Medicines (RVMD) is a focal point of intense market discussion driven by shifting acquisition rumors, initially with AbbVie and now reportedly with Merck exploring a multi-billion dollar deal. The community is highly engaged, dissecting potential buyout valuations while also expressing skepticism regarding the veracity of these unconfirmed reports amidst rapid sector M&A activity. This interest highlights the urgent demand for novel oncology assets, particularly RAS inhibitors, as large pharmaceutical companies navigate impending patent expirations for key drugs.

Federal National Mortgage Association is a government-sponsored company, which engages in the provision of liquidity for purchases of homes and financing of multifamily rental housing and refinancing existing mortgages. It operates through the Single-Family and Multifamily segments. The Single-Family segment offers liquidity to the mortgage market and increases the availability and affordability of housing for single families. The Multifamily segment includes guaranty fees on mortgages and on multifamily mortgage loans. The company was founded in 1938 and is headquartered in Washington, DC.

Federal National Mortgage Association

Federal National Mortgage Association (FNMA) is trending as recent statements from political figures, including plans to direct Fannie Mae and Freddie Mac to purchase $200 billion in mortgage bonds, fuel speculation about its future. The community widely interprets these actions, alongside bullish remarks from prominent investors and administration officials, as strong indicators of an imminent exit from conservatorship and a potential uplisting or IPO, driving conversations about a significant shift in the housing finance sector.

Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

ARDX is trending as investors digest the potential impact of Fosun Pharma's Wan Ti Le being included on China's National Reimbursement Drug List and analysts anticipate target price raises due to strong IBSRELA sales. The community is weighing potential revenue from China and speculating on milestone payments, while also discussing concerns about patent infringement and generic competition. Some investors express frustration with the stock's price movement despite positive developments, awaiting a CMS resolution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
